Charles J. Homcy - 02 Dec 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Yi Ching Yau, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
02 Dec 2021
Net transactions value
$0
Form type
4
Filing time
06 Dec 2021, 19:58:03 UTC
Previous filing
30 Jun 2021
Next filing
15 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Stock Option (right to buy) Award $0 +55,011 $0.000000 55,011 02 Dec 2021 Common Stock 55,011 $40.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.